Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
grade C 17.43 -1.02% -0.18
NVTA closed down 1.02 percent on Friday, May 24, 2019, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical NVTA trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -1.02%
Oversold Stochastic Weakness -1.02%
180 Bearish Setup Bearish Swing Setup -3.27%
Wide Bands Range Expansion -3.27%

Older signals for NVTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Neurology Genetic Disorders Cardiovascular Disorders Genetic Disorder
Is NVTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 26.77
52 Week Low 7.08
Average Volume 1,783,074
200-Day Moving Average 16.3151
50-Day Moving Average 22.6568
20-Day Moving Average 20.46
10-Day Moving Average 18.139
Average True Range 1.182
ADX 31.06
+DI 12.5207
-DI 29.6784
Chandelier Exit (Long, 3 ATRs ) 21.884
Chandelier Exit (Short, 3 ATRs ) 20.776
Upper Bollinger Band 26.1339
Lower Bollinger Band 14.7861
Percent B (%b) 0.23
BandWidth 55.463343
MACD Line -1.5263
MACD Signal Line -1.2852
MACD Histogram -0.2411
Fundamentals Value
Market Cap 758.98 Million
Num Shares 43.5 Million
EPS -2.73
Price-to-Earnings (P/E) Ratio -6.38
Price-to-Sales 9.34
Price-to-Book 5.59
PEG Ratio -0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.24
Resistance 3 (R3) 18.32 18.12 18.11
Resistance 2 (R2) 18.12 17.92 18.09 18.06
Resistance 1 (R1) 17.78 17.79 17.68 17.70 18.01
Pivot Point 17.58 17.58 17.54 17.55 17.58
Support 1 (S1) 17.24 17.38 17.14 17.16 16.85
Support 2 (S2) 17.04 17.25 17.01 16.80
Support 3 (S3) 16.70 17.04 16.76
Support 4 (S4) 16.62